Loading...
Montelukast
India Pharmaceutical Trade Intelligence
Who Supplies Montelukast to India from UNITED STATES
India's montelukast imports from UNITED STATES total $7.2K across 16 shipments from 13 foreign suppliers. SPRING BIO SOLUTION leads with $1.7K in import value; the top 5 suppliers together control 77.0% of this origin. Leading Indian buyers include AZURITY PHARMACEUTICALS INDIA LLP. This corridor reflects India's pharmaceutical import demand for montelukast — a diversified sourcing base with multiple active suppliers from UNITED STATES.
Top foreign suppliers (UNITED STATES) — Ranked by import value
SPRING BIO SOLUTION is the leading Montelukast supplier from UNITED STATES to India, with import value of $1.7K across 1 shipments. The top 5 suppliers — SPRING BIO SOLUTION, Espee Biopharma & Finechem LLC, AMSTERDAM PHARMA (APTEKA RX INC), AGRACE PHARMA, AMSTERDAM PHARMA(APTEKA RX INC.) — collectively account for 77.0% of total import value from this origin.
Top foreign suppliers (UNITED STATES)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | SPRING BIO SOLUTION | $1.7K | 1 | 22.9% |
| 2 | Espee Biopharma & Finechem LLC | $1.3K | 2 | 18.1% |
| 3 | AMSTERDAM PHARMA (APTEKA RX INC) | $1.1K | 2 | 14.7% |
| 4 | AGRACE PHARMA | $970 | 1 | 13.4% |
| 5 | AMSTERDAM PHARMA(APTEKA RX INC.) | $574 | 2 | 7.9% |
| 6 | AMSTERDAM PHARMA (APTEKA RX INC.) | $347 | 1 | 4.8% |
| 7 | AMSTERDAM PHARMA APTEKA RX INC | $346 | 1 | 4.8% |
| 8 | ESPEE BIOPHARMA & FINECHEM LLC. | $330 | 1 | 4.5% |
| 9 | Espee Biopharma Finechem LLC | $328 | 1 | 4.5% |
| 10 | DELUXE HEALTHGROUP INC | $294 | 1 | 4.1% |
| 11 | M S RISING PHARMA HOLDINGS | $10 | 1 | 0.1% |
| 12 | THE MASTER OF WHISTLER SPIRIT | $8 | 1 | 0.1% |
| 13 | M S AUROBINDO 279PHR | $6 | 1 | 0.1% |
Showing top 13 of 13 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from UNITED STATES)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | AZURITY PHARMACEUTICALS INDIA LLP | $2.4K | 5 | 33.0% |
| 2 | LAURUS LABS LIMITED | $1.7K | 1 | 22.9% |
| 3 | HETERO LABS LIMITED | $970 | 1 | 13.4% |
| 4 | CLIANTHA RESEARCH LIMITED | $677 | 2 | 9.3% |
| 5 | SLAYBACK PHARMA INDIA LLP | $657 | 1 | 9.1% |
| 6 | DR.REDDY'S LABORATORIES LTD | $574 | 2 | 7.9% |
| 7 | AXIS CLINICALS LIMITED | $294 | 1 | 4.1% |
| 8 | AUROBINDO PHARMA LTD | $16 | 2 | 0.2% |
| 9 | 3CUBE MEDICARE PRIVATE LIMITED | $8 | 1 | 0.1% |
Import Statistics
- Import Value
- $7.2K
- Shipments
- 16
- Foreign Suppliers
- 13
- Indian Buyers
- 9
- Avg. Shipment
- $453
Other Montelukast Import Origins
Related Analysis
Frequently Asked Questions — Montelukast Imports from UNITED STATES
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Montelukast suppliers from UNITED STATES to India?
The top Montelukast suppliers from UNITED STATES to India include SPRING BIO SOLUTION, Espee Biopharma & Finechem LLC, AMSTERDAM PHARMA (APTEKA RX INC). The leading supplier is SPRING BIO SOLUTION with import value of $1.7K USD across 1 shipments. India imported Montelukast worth $7.2K USD from UNITED STATES in total across 16 shipments.
QHow much Montelukast does India import from UNITED STATES?
India imported Montelukast worth $7.2K USD from UNITED STATES across 16 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Montelukast from UNITED STATES?
The main Indian buyers of Montelukast sourced from UNITED STATES include AZURITY PHARMACEUTICALS INDIA LLP, LAURUS LABS LIMITED, HETERO LABS LIMITED. The largest buyer is AZURITY PHARMACEUTICALS INDIA LLP with $2.4K in imports across 5 shipments.
QWhat is the total value of Montelukast imports from UNITED STATES to India?
The total value of Montelukast imports from UNITED STATES to India is $7.2K USD, across 16 shipments and 13 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: UNITED STATES to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Montelukast.
- 2.Supplier/Buyer Matching: 13 foreign suppliers from UNITED STATES and 9 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $7.2K aggregated from 16 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
16 Verified Shipments
13 suppliers, 9 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists